A. .. Généralités,

H. .. Le-système,

. .. Physiopathologie,

. .. Rejets,

D. .. Anticorps-anti-hla,

B. Compatibilité-hla-en and T. .. ,

C. Problématique and .. .. Objectif-de-l'étude,

A. .. ,

. .. Abstract,

. Materals and . .. Methods,

. .. Results,

. .. Discussion,

. .. Conclusion,

. .. Acknowledgments, , p.61

. .. Figures,

D. .. Ouverture,

A. Avantages-de-notre-cohorte and .. .. ,

B. .. Résultats,

C. Limites-de-notre-cohorte and .. .. ,

. , 84 1. Hypothèse du « non-self-self »

. .. Conclusion,

R. .. ,

G. Opelz and B. Dohler, Effect of Human Leukocyte Antigen Compatibility on Kidney Graft Survival: Comparative Analysis of Two Decades, Transplantation, vol.84, issue.2, pp.137-180, 2007.

J. E. Cooper, J. Gralla, L. Cagle, R. Goldberg, L. Chan et al., Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes, Transplantation, vol.91, issue.10, pp.1103-1112, 2011.

, Human leukocyte antigen epitope antigenicity and immunogenicity, Activité de greffe-rein-rapport Agence Biomédecine, vol.19, pp.428-463, 2014.

R. J. Duquesnoy, M. Marrari, A. Mulder, F. Claas, J. Mostecki et al., Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies, Hum Immunol, vol.73, issue.3, pp.267-77, 2012.

V. Kosmoliaptsis, L. D. Sharples, and A. Chaudhry, HLA class I amino acid sequencebased matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation, Hum Immunol, vol.71, issue.9, pp.851-857, 2010.
DOI : 10.1016/j.humimm.2010.06.003

C. Wiebe, D. Pochinco, and T. D. Blydt-hansen, Class II HLA Epitope Matching-A Strategy to Minimize De Novo Donor-Specific Antibody Development and Improve Outcomes, Am J Transplant, vol.13, issue.12, pp.3114-3136, 2013.

C. Wiebe, T. E. Nevins, W. N. Robiner, W. Thomas, A. J. Matas et al., The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival, Am J Transplant, vol.15, issue.8, pp.2197-202, 2015.

V. Kosmoliaptsis, D. H. Mallon, Y. Chen, E. M. Bolton, J. A. Bradley et al.,

, Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching, Am J Transplant, vol.16, issue.7, pp.2139-2186, 2016.

C. Wiebe, I. W. Gibson, and T. D. Blydt-hansen, Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.12, issue.5, pp.1157-67, 2012.

M. Willicombe, P. Brookes, and R. Sergeant, De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy, Transplantation, vol.94, issue.2, pp.172-179, 2012.

C. Lefaucheur, D. Viglietti, and C. Bentlejewski, IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury, J Am Soc Nephrol, vol.27, issue.1, pp.293-304, 2016.

P. Lee, L. Zhu, P. I. Terasaki, and M. J. Everly, HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft Loss, Transplantation, vol.88, issue.4, pp.568-74, 2009.

R. Sapir-pichhadze, K. Tinckam, and K. Quach, HLA-DR and-DQ Eplet Mismatches and Transplant Glomerulopathy: A Nested Case-Control Study, Am J Transplant, vol.15, issue.1, pp.137-185, 2015.

E. Silva, A. Alba, and A. Castro, Evaluation of HLA Matchmaker Compatibility as Predictor of Graft Survival and Presence of Anti-HLA Antibodies, Transplant Proc, vol.42, issue.1, pp.266-275, 2010.

V. Kosmoliaptsis, L. D. Sharples, A. N. Chaudhry, D. J. Halsall, J. A. Bradley et al.,

, Predicting HLA Class II Alloantigen Immunogenicity From the Number and Physiochemical Properties of Amino Acid Polymorphisms, Transplantation, 2011.

P. J. Morris, R. J. Johnson, S. V. Fuggle, M. A. Belger, and J. D. Briggs, Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA), Lancet Lond Engl, vol.354, issue.9185, pp.1147-52, 1999.

Y. Huang, D. Ramon, F. L. Luan, R. Sung, and M. Samaniego, Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation, Clin Transpl, pp.247-56, 2012.

(. Kaneku, O. Leary, J. G. Banuelos, and N. , De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.13, issue.6, pp.1541-1549, 2013.

P. I. Terasaki and M. Ozawa, Predicting kidney graft failure by HLA antibodies: a prospective trial, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.4, issue.3, pp.438-481, 2004.

T. H. Tran, B. Döhler, A. Heinold, S. Scherer, A. Ruhenstroth et al., Deleterious Impact of Mismatching for Human Leukocyte Antigen-C in Presensitized Recipients of Kidney Transplants, Transplantation, vol.92, issue.4, pp.419-444, 2011.

A. R. Tambur, J. Rosati, S. Roitberg, D. Glotz, J. J. Friedewald et al., Epitope Analysis of HLA-DQ Antigens: What Does the Antibody See?, Transplantation, vol.98, issue.2, pp.157-66, 2014.

G. Laux, J. Mytilineos, and G. Opelz, Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation, Transplantation, vol.77, issue.6, pp.902-909, 2004.

A. K. Baranwal and N. K. Mehra, Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation. Front Immunol, Curr Opin Immunol, vol.8, issue.5, pp.569-72, 2009.

E. D. Carosella, From MAC to HLA: Professor Jean Dausset, the pioneer, Hum Immunol, vol.70, issue.9, pp.661-663, 2009.

T. Shiina, G. Tamiya, A. Oka, N. Takishima, and H. Inoko, Genome sequencing analysis of the 1.8 Mb entire human MHC class I region, vol.167, pp.193-202, 1999.

. Who-nomenclature-committee, Nomenclature for Factors of the HL-A System, 1968.

, HLA Nomenclature @ hla.alleles.org, 2017.

M. J. Hickey, N. M. Valenzuela, and E. F. Reed, Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen. Front Immunol, vol.7, 2016.

A. E. Morelli, Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells, Blood, vol.104, issue.10, pp.3257-66, 2004.

T. Kurosaki, K. Kometani, and W. Ise, Memory B cells, Nat Rev Immunol, vol.15, issue.3, pp.149-59, 2015.

E. Pouliquen, A. Koenig, and C. C. Chen, Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology, Am J Transplant, vol.7, issue.1, pp.28-41, 2015.

M. J. Everly, L. M. Rebellato, and C. E. Haisch, Incidence and impact of de novo donor-specific alloantibody in primary renal allografts, Transplantation, vol.95, issue.3, pp.410-417, 2013.

J. E. Cooper, J. Gralla, L. Cagle, R. Goldberg, L. Chan et al., Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes, Transplantation, vol.91, issue.10, pp.1103-1112, 2011.

M. Jeannet, V. W. Pinn, M. H. Flax, H. J. Winn, and P. S. Russell, Humoral Antibodies in Renal Allotransplantation in Man, N Engl J Med, vol.282, issue.3, pp.111-118, 1970.

Q. Mao, P. I. Terasaki, and J. Cai, Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.7, issue.4, pp.864-71, 2007.

N. Lachmann, P. I. Terasaki, and K. Budde, Anti-human leukocyte antigen and donorspecific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts, Transplantation, vol.87, issue.10, pp.1505-1518, 2009.

P. Lee, L. Zhu, P. I. Terasaki, and M. J. Everly, HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft Loss, Transplantation, vol.88, issue.4, pp.568-74, 2009.

P. I. Terasaki and M. Ozawa, Predicting kidney graft failure by HLA antibodies: a prospective

, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.4, issue.3, pp.438-481, 2004.

G. Einecke, B. Sis, and J. Reeve, Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure, Am J Transplant, vol.9, issue.11, pp.2520-2551, 2009.

J. E. Worthington, A. Mcewen, L. J. Mcwilliam, M. L. Picton, and S. Martin, Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome, Transplantation, vol.83, issue.4, pp.398-403, 2007.

C. Wiebe, I. W. Gibson, and T. D. Blydt-hansen, Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific Antibody: Post-dn DSA Clinical Histologic Progression, Am J Transplant, vol.15, issue.11, pp.2921-2951, 2015.

C. Wiebe, I. W. Gibson, and T. D. Blydt-hansen, Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.12, issue.5, pp.1157-67, 2012.

A. Loupy, D. Vernerey, and D. Viglietti, Determinants and Outcomes of Accelerated ArteriosclerosisNovelty and Significance, Circ Res, vol.117, issue.5, pp.470-482, 2015.

D. P. Lucas, M. S. Leffell, and A. A. Zachary, Differences in Immunogenicity of HLA Antigens and the Impact of Cross-Reactivity on the Humoral Response, Transplantation, vol.99, issue.1, pp.77-85, 2015.

M. Willicombe, P. Brookes, and R. Sergeant, De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy, Transplantation, vol.94, issue.2, pp.172-179, 2012.

J. M. Devos, A. O. Gaber, and R. J. Knight, Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation, Kidney Int, vol.82, issue.5, pp.598-604, 2012.

O. Aubert, A. Loupy, and L. Hidalgo, Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients, J Am Soc Nephrol, 2017.

G. Opelz and B. Dohler, Effect of Human Leukocyte Antigen Compatibility on Kidney Graft Survival: Comparative Analysis of Two Decades, Transplantation, vol.84, issue.2, pp.137-180, 2007.

J. M. Devos, A. O. Gaber, and L. D. Teeter, Intermediate-Term Graft Loss After Renal Transplantation is Associated With Both Donor-Specific Antibody and Acute Rejection, Transplantation, vol.97, issue.5, pp.534-574, 2014.

P. J. Morris, R. J. Johnson, S. V. Fuggle, M. A. Belger, and J. D. Briggs, Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant

, Lancet Lond Engl, vol.354, issue.9185, pp.1147-52, 1999.

G. Opelz, Very short ischaemia is not the answer, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc-Eur Ren Assoc, vol.17, issue.5, pp.715-721, 2002.

N. R. El-awar, T. Akaza, P. I. Terasaki, and A. Nguyen, Human Leukocyte Antigen Class I Epitopes: Update to 103 Total Epitopes, Including the C Locus, Transplantation, vol.84, issue.4, pp.532-572, 2007.

N. El-awar, P. I. Terasaki, A. Nguyen, M. Lias, and N. Conger, New HLA class I epitopes defined by murine monoclonal antibodies, Hum Immunol, vol.71, issue.5, pp.456-61, 2010.

A. R. Tambur and F. Claas, HLA Epitopes as Viewed by Antibodies: What Is it All About?: HLA Epitopes as Viewed by Antibodies, Am J Transplant, vol.15, issue.5, pp.1148-54, 2015.

R. J. Duquesnoy, HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients, Transplantation proceedings, pp.493-497, 2001.

R. J. Duquesnoy and M. Marrari, HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes, Hum Immunol, vol.63, issue.5, pp.353-363, 2002.

R. J. Duquesnoy, J. Howe, and S. Takemoto, HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increas the number of compatible donors for highly sensitized patients1, Transplantation, vol.75, issue.6, pp.889-97, 2003.

R. J. Duquesnoy, M. Witvliet, I. Doxiadis, H. De-fijter, and F. Claas, HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates, Transpl Int Off J Eur Soc Organ Transplant, vol.17, issue.1, pp.22-30, 2004.

R. P. Valentini, S. L. Nehlsen-cannarella, and S. A. Gruber, Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients, Pediatr Transplant, vol.11, issue.1, pp.77-81, 2007.

R. J. Duquesnoy, S. Takemoto, and P. De-lange, HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival1, Transplantation, vol.75, issue.6, pp.884-893, 2003.

M. Dankers, M. D. Witvliet, and D. L. Roelen, The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigen, Transplantation, vol.77, issue.8, pp.1236-1245, 2004.

A. Haririan, O. Fagoaga, and H. Daneshvar, Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly AfricanAmerican renal transplant cohort, Clin Transplant, vol.20, issue.2, pp.226-259, 2006.

G. Laux, J. Mytilineos, and G. Opelz, Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation, Transplantation, vol.77, issue.6, pp.902-909, 2004.

R. J. Duquesnoy, Y. Awadalla, and J. Lomago, Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes, Transpl Immunol, vol.18, issue.4, pp.352-60, 2008.

P. M. Sullivan, P. Warner, and M. S. Kemna, HLA molecular epitope mismatching and long

P. Singh, E. J. Filippone, and B. W. Colombe, Sensitization trends after renal allograft failure: the role of DQ eplet mismatches in becoming highly sensitized, Clin Transplant, vol.30, issue.1, pp.71-80, 2016.

F. H. Claas and I. I. Doxiadis, Management of the highly sensitized patient, Curr Opin Immunol, vol.21, issue.5, pp.569-72, 2009.

F. Claas, A. Rahmel, and I. Doxiadis, Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program, Transplantation, vol.88, issue.4, pp.447-52, 2009.

E. Silva, A. Alba, and A. Castro, Evaluation of HLA Matchmaker Compatibility as Predictor of Graft Survival and Presence of Anti-HLA Antibodies, Transplant Proc, vol.42, issue.1, pp.266-275, 2010.

R. Sapir-pichhadze, K. Tinckam, and K. Quach, HLA-DR and-DQ Eplet Mismatches and Transplant Glomerulopathy: A Nested Case-Control Study, Am J Transplant, vol.15, issue.1, pp.137-185, 2015.

C. Wiebe, D. Pochinco, and T. D. Blydt-hansen, Class II HLA Epitope Matching-A Strategy to Minimize De Novo Donor-Specific Antibody Development and Improve Outcomes, Am J Transplant, vol.13, issue.12, pp.3114-3136, 2013.

C. Wiebe, T. E. Nevins, W. N. Robiner, W. Thomas, A. J. Matas et al., The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival, Am J Transplant, vol.15, issue.8, pp.2197-202, 2015.

V. Kosmoliaptsis, D. H. Mallon, Y. Chen, E. M. Bolton, J. A. Bradley et al., Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching, Am J Transplant, vol.16, issue.7, pp.2139-2186, 2016.

L. T. Chong, Y. Duan, L. Wang, I. Massova, and P. A. Kollman, Molecular dynamics and free-energy calculations applied to affinity maturation in antibody 48G7, Proc Natl Acad Sci, vol.96, issue.25, pp.14330-14335, 1999.

N. Sinha, S. Mohan, C. A. Lipschultz, and S. Sj, Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity, Biophys J, vol.83, issue.6, pp.2946-2968, 2002.

E. García-guerrero, J. A. Pérez-simón, L. I. Sánchez-abarca, I. Díaz-moreno, D. La-rosa et al., The Dynamics of the Human Leukocyte Antigen Head Domain Modulates Its Recognition by the T-Cell Receptor, vol.11, p.154219, 2016.

V. Kosmoliaptsis, T. R. Dafforn, A. N. Chaudhry, D. J. Halsall, J. A. Bradley et al., Highresolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes, Hum Immunol, vol.72, issue.11, pp.1049-59, 2011.

V. Kosmoliaptsis, M. M. Jöris, and D. H. Mallon, Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT, Bone Marrow Transplant, vol.50, issue.4, pp.540-544, 2015.

D. Mallon, C. Kling, J. A. Bradley, C. Taylor, D. Kabelitz et al., Computational scoring system to predict HLA immunogenicity, The Lancet, vol.387, p.68, 2016.

V. Kosmoliaptsis, A. N. Chaudhry, and L. D. Sharples, Predicting HLA Class I Alloantigen Immunogenicity From the Number and Physiochemical Properties of Amino Acid Polymorphisms, Transplantation, vol.88, issue.6, pp.791-799, 2009.

V. Kosmoliaptsis, L. D. Sharples, A. N. Chaudhry, D. J. Halsall, J. A. Bradley et al., Predicting HLA Class II Alloantigen Immunogenicity From the Number and Physiochemical Properties of Amino Acid Polymorphisms, Transplantation, vol.91, issue.2, pp.183-90, 2011.

V. Kosmoliaptsis, L. D. Sharples, and A. Chaudhry, HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation, Hum Immunol, vol.71, issue.9, pp.851-857, 2010.
DOI : 10.1016/j.humimm.2010.06.003

Y. W. Sijpkens, I. I. Doxiadis, D. Fijter, and J. W. , Sharing cross-reactive groups of MHC class I improves long-term graft survival, Kidney Int, vol.56, issue.5, pp.1920-1927, 1999.

L. E. Becker, C. Morath, and C. Suesal, Immune mechanisms of acute and chronic rejection, Clin Biochem, vol.49, issue.4-5, pp.320-323, 2016.

C. L. Butler, N. M. Valenzuela, K. A. Thomas, and E. F. Reed, Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection, J Immunol Res, vol.2017, pp.1-9, 2017.
DOI : 10.1155/2017/7903471

URL : http://downloads.hindawi.com/journals/jir/2017/7903471.pdf

Y. Huang, D. Ramon, F. L. Luan, R. Sung, and M. Samaniego, Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation, Clin Transpl, pp.247-56, 2012.

(. Kaneku, O. Leary, J. G. Banuelos, and N. , De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.13, issue.6, pp.1541-1549, 2013.

O. Aubert, M. Bories, and C. Suberbielle, Risk of Antibody-Mediated Rejection in Kidney Transplant Recipients With Anti-HLA-C Donor-Specific Antibodies, Am J Transplant, vol.14, issue.6, pp.1439-1484, 2014.

A. R. Tambur, J. Rosati, S. Roitberg, D. Glotz, J. J. Friedewald et al., Epitope Analysis of HLA-DQ Antigens: What Does the Antibody See?, Transplantation, vol.98, issue.2, pp.157-66, 2014.

J. J. Kim, R. Balasubramanian, and G. Michaelides, The Clinical Spectrum of De Novo DonorSpecific Antibodies in Pediatric Renal Transplant Recipients: De Novo DSA in Pediatric Renal Transplants, Am J Transplant, vol.14, issue.10, pp.2350-2358, 2014.

C. F. Bryan, V. Chadha, and B. A. Warady, Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm, Pediatr Transplant, vol.20, issue.7, pp.926-956, 2016.

G. J. Dreyer, A. C. Hemke, M. Reinders, and J. W. De-fijter, Transplanting the elderly: Balancing aging with histocompatibility, Transplant Rev, vol.29, issue.4, pp.205-216, 2015.

R. J. Duquesnoy, The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity: Antibody response to an HLA mismatch, Int J Immunogenet, vol.39, issue.1, pp.1-9, 2012.

R. J. Duquesnoy, M. Marrari, A. Mulder, R. J. Duquesnoy, M. Marrari et al., First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry, Tissue Antigens, vol.83, issue.6, pp.391-400, 2014.

R. J. Duquesnoy, M. Marrari, and A. R. Tambur, First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry, Hum Immunol, vol.75, issue.11, pp.1097-103, 2014.

D. J. Steele, T. M. Laufer, and S. T. Smiley, Two levels of help for B cell alloantibody production, J Exp Med, vol.183, issue.2, pp.699-703, 1996.

M. K. Dankers, D. L. Roelen, and N. J. Nagelkerke, The HLA-DR phenotype of the responder is predictive of humoral response against HLA class i antigens, Hum Immunol, vol.65, issue.1, pp.13-22, 2004.

T. Fuller and A. Fuller, The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder, Transplantation, vol.68, issue.2, pp.173-82, 1999.

E. Spierings, C. J. Vermeulen, and M. H. Vogt, Identification of HLA class II-restricted HYspecific T-helper epitope evoking CD4+ T-helper cells in HY-mismatched transplantation, The Lancet, vol.362, issue.9384, pp.610-615, 2003.

(. Otten, J. Calis, C. Ke?mir, A. D. Van-zuilen, and E. Spierings,

K. Geneugelijk, G. Hönger, and H. Van-deutekom, Predicted Indirectly Recognizable HLA Epitopes Presented by HLA-DRB1 Are Related to HLA Antibody Formation During Pregnancy: PIRCHE-II in HLA Antibody Formation, Am J Transplant, vol.15, issue.12, pp.3112-3134, 2015.

T. M. Conlon, J. L. Cole, and R. Motallebzadeh, Unlinked Memory Helper Responses Promote Long-Lasting Humoral Alloimmunity, J Immunol, vol.189, issue.12, pp.5703-5715, 2012.
DOI : 10.4049/jimmunol.1202257

URL : http://www.jimmunol.org/content/189/12/5703.full.pdf